SARA COX may be broken but she’s not beaten after the toughest day yet of her Radio 2 Great Northern Marathon for Children In ...

Stephanie Lowe reflects on what the government's new curriculum – with lessons on fake news, AI and financial literacy ...

Apple kept Split View side-by-side multitasking in iPadOS 26 — despite what you might have read online. And setting it up is as easy as a couple of flicks of your finger. Here’s how to keep using ...

Alice Bradbury receives funding from the Helen Hamlyn Trust which funds the Helen Hamlyn Centre for Pedagogy at UCL. She is a member of the Labour Party and the Universities and College Union. The ...

New research has jolted the school-gate chat, revealing families are rethinking what counts as “ready” for Reception in 2025.

Sony’s Bravia 8 II was voted the top TV of 2025 by a panel of experts — including our own Nilay Patel. The dazzling QD-OLED ...

The lululemon Split Shift fills that gap in the brand’s line of shoes, offering a lightweight everyday trainer for speedier efforts. The brand’s six-day ultramarathon event, Further, was used as a ...

Oracle shares have climbed nearly 400% over the past few years. The company’s revenue is taking off thanks to demand from AI customers for cloud infrastructure. 10 stocks we like better than Oracle › ...

Nov 5(Reuters) - Companies announcing multi-billion dollar investments in artificial intelligence have raised concerns about the formation of a bubble reminiscent of the dotcom boom and bust.

IonQ’s current share price is well below the levels that typically trigger forward stock splits. A reverse split isn’t needed because the share price is also far above any delisting threshold.

Supporting these children is important. Students who wrestle with reading are more likely to later experience anxiety and depression. Adults with reading difficulties are also more likely to be ...

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.